Company page

Glaxosmithkline Pharmaceuticals Limited

Glaxosmithkline Pharmaceuticals Limited, traded under the ticker GLAXO, operates in the Indian market with a market capitalization of approximately 4.41 billion USD. The company focuses on developing and manufacturing a range of pharmaceutical products. Its commitment to healthcare innovation positions it as a significant player in the Indian pharmaceutical industry.

GLAXO:NSEUpdated July 31, 2026
Glaxosmithkline Pharmaceuticals Limited logo
Ticker
GLAXO:NSE
Asset type
Stock
Market cap
$4.63B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NSE
Currency
INR